Skandinaviska Enskilda Banken (SEB)
ANRO icon

Skandinaviska Enskilda Banken (SEB)’s Alto Neuroscience ANRO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,721
Closed -$74.4K – 884
2024
Q4 		$74.4K Buy
+17,721
New +$111K ﹤0.01% 777

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ANRO Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Alto Neuroscience (ANRO) in Q1 2025, closing a stake of 17,721 shares — an estimated $74.4K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ANRO in Q4 2024 and held it in 1 quarter. The position peaked at $74.4K in Q4 2024. 83 funds tracked by Wall St. Rank hold ANRO as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Alto Neuroscience position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 17,721 Alto Neuroscience shares in Q1 2025, an estimated $74.4K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Alto Neuroscience in Q4 2024 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Alto Neuroscience position peaked at $74.4K in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.